CSP and Eli Lilly held business talks
On 28 February 2007, Mr. Liu Wei, Chairman and President and Mr. Zhang Ying, Executive Director met with Chen Guozhan, Head of Senior Asset Protection, Lilly Asia, Michael J. Muller, Head of Global Anti-counterfeit Operations, Lilly and Richard Kjeldgaard, Vice President, American Drug and Pharmaceutical Investigation Association. The two parties held intensive discussions on IPR protection and commercial investigation and exchanged views on IPR protection cases, systems and status quo. Both expressed strong desires for in-depth cooperation.
